[1. IFKF. World Kidney Day -Kidney Health for All. 2015 [cited 17.08.2015]; Available from: http://www.worldkidneyday.org/topics/diabetes/http://www.niddk.nih.gov/health-information/health-topics/kidney-disease/kidney-disease-of-diabetes/Documents/kdd_508.pdf]Search in Google Scholar
[2. WHO. Diabetes Fact sheet N°312. 2015 January 2015 [cited 28.02.2015]; Available from: http://www.who.int/mediacentre/factsheets/fs312/en/]Search in Google Scholar
[3. WHO. Noncommunicable diseases - Fact sheet 2015 January 2015 [cited 31.07.2015]; Available from: http://www.who.int/mediacentre/factsheets/fs355/en/]Search in Google Scholar
[4. BATUMAN V, SOMAN A, SCHMIDT R, SOMAN S. Diabetic Nephropathy. [cited 07.05.2015] Available from: http://emedicine.medscape.com/article/238946-overview.]Search in Google Scholar
[5. ADA, Standards of medical care in diabetes-2015 abridged for primary care providers. Clin Diabetes. 2015; 33(2): 97-111.10.2337/diaclin.33.2.97]Search in Google Scholar
[6. HOTCHKISS RS, STRASSER A, McDUNN JE, SWANSON PE. Cell death. N Engl J Med. 2009; 361(16): 1570-83.10.1056/NEJMra0901217]Search in Google Scholar
[7. ELMORE S. Apoptosis: a review of programmed cell death. Toxicol Pathol. 2007; 35(4): 495-516.10.1080/01926230701320337]Search in Google Scholar
[8. DING Y, CHOI ME. Autophagy in diabetic nephropathy. J Endocrinol. 2015; 224(1): R15-30.10.1530/JOE-14-0437]Search in Google Scholar
[9. SANCHEZ-NINO MD, BENITO-MARTIN A, ORTIZ A. New paradigms in cell death in human diabetic nephropathy. Kidney Int. 2010; 78(8): 737-44.10.1038/ki.2010.270]Search in Google Scholar
[10. SINKOVICS JG. Programmed cell death (apoptosis): its virological and immunological connections (a review). Acta Microbiol Hung. 1991; 38(3-4): 321-34.]Search in Google Scholar
[11. CABON L, MARTINEZ-TORRES AC, SUSIN SA. Programmed cell death comes in many flavors. Med Sci (Paris). 2013; 29(12): 1117-24.10.1051/medsci/20132912015]Search in Google Scholar
[12. ACEHAN D, JIANG X, MORGAN DG, HEUSER JE, WANG X, AKEY CW. Three-dimensional structure of the apoptosome: implications for assembly, procaspase-9 binding, and activation. Mol Cell. 2002; 9(2): 423-32.10.1016/S1097-2765(02)00442-2]Search in Google Scholar
[13. OO TF, SIMAN R, BURKE RE. Distinct nuclear and cytoplasmic localization of caspase cleavage products in two models of induced apoptotic death in dopamine neurons of the substantia nigra. Exp Neurol. 2002; 175(1): 1-9.10.1006/exnr.2002.788112009755]Search in Google Scholar
[14. ALPERN R, CAPLAN M, MOE O. Seldin and Giebisch's the kidney; Physiology & pathophysiology. Academic Press; 2012. p. 2605-23.]Search in Google Scholar
[15. RANE MJ, SONG Y, JIN S, BARATI MT, WU R, KAUSAR H, et al. Interplay between Akt and p38 MAPK pathways in the regulation of renal tubular cell apoptosis associated with diabetic nephropathy. Am J Physiol Renal Physiol. 2010; 298(1): F49-61.10.1152/ajprenal.00032.2009280612019726550]Search in Google Scholar
[16. WOLF G, SCHROEDER R, ZIYADEH FN, THAISS F, ZAHNER G, STAHL RA. High glucose stimulates expression of p27Kip1 in cultured mouse mesangial cells: relationship to hypertrophy. Am J Physiol. 1997; 273(3 Pt 2): F348-56.10.1152/ajprenal.1997.273.3.F3489321907]Search in Google Scholar
[17. DAVIS RJ. The mitogen-activated protein kinase signal transduction pathway. J Biol Chem. 1993; 268(20): 14553-6.10.1016/S0021-9258(18)82362-6]Search in Google Scholar
[18. MARTIN AG, FEARNHEAD HO. Apocytochrome c blocks caspase-9 activation and Bax-induced apoptosis. J Biol Chem. 2002; 277(52): 50834-41.10.1074/jbc.M209369200]Search in Google Scholar
[19. YANG E, ZHA J, JOCKEL J, BOISE LH, THOMPSON CB, KORSMEYER SJ. Bad, a heterodimeric partner for Bcl-XL and Bcl-2, displaces Bax and promotes cell death. Cell. 1995; 80(2): 285-91.10.1016/0092-8674(95)90411-5]Search in Google Scholar
[20. NEWMEYER DD, BOSSY-WETZEL E, KLUCK RM, WOLF BB, BEERE HM, GREEN DR. Bcl-xL does not inhibit the function of Apaf-1. Cell Death Differ. 2000; 7(4): 402-7.10.1038/sj.cdd.440066510773825]Search in Google Scholar
[21. ALMOND JB, COHEN GM. The proteasome: a novel target for cancer chemotherapy. Leukemia. 2002; 16(4): 433-43.10.1038/sj.leu.240241711960320]Search in Google Scholar
[22. TOWNS R, PIETROPAOLO M, WILEY JW. Stimulation of autophagy by autoantibody-mediated activation of death receptor cascades. Autophagy. 2008; 4(5): 715-6.10.4161/auto.633618560272]Search in Google Scholar
[23. FALEIRO L, LAZEBNIK Y. Caspases disrupt the nuclear-cytoplasmic barrier. J Cell Biol. 2000; 151(5): 951-9.10.1083/jcb.151.5.951217435311085998]Search in Google Scholar
[24. KRAMER A, LIASHKOVICH I, OBERLEITHNER H, SHAHIN V. Caspase-9-dependent decrease of nuclear pore channel hydrophobicity is accompanied by nuclear envelope leakiness. Nanomedicine. 2010; 6(5): 605-11.10.1016/j.nano.2010.04.00620470907]Search in Google Scholar
[25. BĂLĂŞESCU E, DUŢĂ I, RUSU MC. Human diabetic nephropathy: TRADD-positive and bcl2-negative podocytes. Therapeutics, Pharmacology and Clinical Toxicology. 2013;17(3):115-8. ]Search in Google Scholar